The increasing interest in addressing mental health issues in the workplace includes a rising interest in alternative therapies. One of those alternative therapies that is gaining popularity is the use of psychedelics like Ketamine to treat depression, PTSD, and other behavioral health disorders. The number of startups offering Ketamine services is growing to meet the demand. Should employers offer these treatments to employees to improve their well-being? What are the legal risks? This webinar will answer those questions as well as provide a brief background in government regulation of drugs both at the state and federal levels.
View Resource